Prophylactic methylxanthine for prevention of apnoea in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Prophylactic Methylxanthine for Prevention of Apnoea in Preterm Infants." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439421/all/Cognitive_behavioural_therapy_for_tinnitus_New. Accessed 29 March 2024.
Prophylactic methylxanthine for prevention of apnoea in preterm infants. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439421/all/Cognitive_behavioural_therapy_for_tinnitus_New. Accessed March 29, 2024.
Prophylactic methylxanthine for prevention of apnoea in preterm infants. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439421/all/Cognitive_behavioural_therapy_for_tinnitus_New
Prophylactic Methylxanthine for Prevention of Apnoea in Preterm Infants [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439421/all/Cognitive_behavioural_therapy_for_tinnitus_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Prophylactic methylxanthine for prevention of apnoea in preterm infants
ID - 439421
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439421/all/Cognitive_behavioural_therapy_for_tinnitus_New
DB - Evidence Central
DP - Unbound Medicine
ER -